1 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Sacituzumab Tirumotecan as Second-Line Treatment for Penile Cancersquamous cell carcinoma of penisNot yet recruitingPhase 22026-09-11NCT07815197